RadioMedix and Curium Announce FDA Fast Track Designation For 64Cu-Dotatate.
09. Januar 2019 01:00 ET
|
RadioMedix Inc.
Houston, TX and St. Louis, MO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that their investigational diagnostic radiopharmaceutical,...